
HKU launches clinical trial in Hong Kong to treat chronic hepatitis B patients
The University of Hong Kong (HKU) has launched a clinical trial for a gene-related therapy aimed at treating chronic hepatitis B infection, giving patients hope for a cure in the future. Professor Yuen Man-fung, chief of the division of gastroenterology and hepatology at HKU’s medical faculty, said on Thursday that existing medication for hepatitis B…